[1] PARK S．Polyphenol compound as a transcription factor inhibitor [J]．Nutrients, 2015, 7(11): 8987-9004．
[2] TEWARI D, NABAVI S F, NABAVI S M, et al．Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention [J]．Pharmacol Res, 2018, 128: 366-375．
[3] TROP-STEINBERG S, AZAR Y．AP-1 expression and its clinical relevance in immune disorders and cancer [J]．Am J Med Sci, 2017, 353(5): 474-483．
[4] BEJJANI F, EVANNO E, ZIBARA K, et al．The AP-1 transcriptional complex: Local switch or remote command[J]．Biochim Biophys Acta Rev Cancer, 2019, 1872(1): 11-23．
[5] SHAULIAN E, KARIN M．AP-1 as a regulator of cell life and death [J]．Nat Cell Biol, 2002, 4(5): E131-E136．
[6] YE N, DING Y, WILD C, et al．Small molecule inhibitors targeting activator protein 1 (AP-1) [J]．J Med Chem,2014, 57(16): 6930-6948．
[7] BAKIRI L, HAMACHER R, GRA?A O, et al．Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation [J]．J Exp Med, 2017, 214(5):1387-1409．
[8] KAJANNE R, MIETTINEN P, TENHUNEN M, e t al．Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells [J]．Int J Oncol,2009, 35(5): 1175-1182．
[9] ANDREOLAS C, KALOGEROPOULOU M, VOULGARI A, et al．Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells [J]．Int J Cancer, 2008, 122(8): 1745-1756．
[10] BELGUISE K, MILORD S, GALTIER F, et al．The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells [J]．Oncogene, 2012, 31(47): 4889-4897．
[11] KHARMAN-BIZ A, GAO H, GHIASVAND R, et al．Expression of activator protein-1 (AP-1) family members in breast cancer [J]．BMC Cancer, 2013, 13: 441．
[12] QIAO Y, HE H, JONSSON P, et al．AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression [J]．J Biol Chem, 2016, 291(10):5068-5079．
[13] ECKERT R L, ADHIKARY G, YOUNG C A, et al．AP1 transcription factors in epidermal differentiation and skin cancer [J]．J Skin Cancer, 2013, 2013: 537028．
[14] BAMBERGER A M, MILDE-LANGOSCH K, R?SSING E,et al．Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators [J]．J Cancer Res Clin Oncol, 2001, 127(9): 545-550．
[15] YOKOYAMA Y, SAGARA M, SATO S, et al．Value of glutathione S-transferase π and the oncogene products c-Jun,c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas [J]．Gynecol Oncol, 1998, 68(3):280-287．
[16] MAR A C, CHU C H, LEE H J, et al．Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce angiogenesis [J]．J Biol Chem, 2015, 290(36): 22212-22224．
[17] KOEHN F E, CARTER G T．The evolving role of natural products in drug discovery [J]．Nat Rev Drug Discov, 2005,4(3): 206-220．
[18] 孙昊鹏, 郭青龙, 尤启冬．基于天然产物的创新药物研究[C]// 2011年全国药物化学学术会议——药物的源头创新论文摘要集．2011年全国药物化学学术会议暨第三届中英药物化学学术会议．广州: 中国药学会, 2011．
[19] LIN C W, SHEN S C, CHIEN C C, e t a l．12-OTetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NFkappaB-dependent MMP-9 expression [J]．J Cell Physiol,2010, 225(2): 472-481．
[20] LIN C W, CHEN P N, CHEN M K, et al．Kaempferol reduces matrix metalloproteinase-2 expression by downregulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells [J]．PLoS One, 2013, 8(11):e80883．
[21] CHEN H J, LIN C M, LEE C Y, et al．Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells [J]．Oncol Rep, 2013, 30(2): 925-932．
[22] LI C, ZHAO Y, YANG D, et al．Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9 [J]．Biochem Cell Biol, 2015, 93(1):16-27．
[23] CHEN P, LU N, LING Y, et al．Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9 [J]．Toxicology, 2011, 282(3): 122-128．
[24] DASTPEYMAN M, MOTAMED N, AZADMANESH K,et al．Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line,MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI [J]．Med Oncol, 2012,29(4): 2512-2518．
[25] BERGHEIM I, BODE C, PARLESAK A．Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma [J]．BMC Gastroenterol, 2005, 5: 34．
[26] GU Y, ZHU C F, DAI Y L, et al．Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma[J]．World J Gastroenterol, 2009, 15(39): 4952-4957．
[27] WANG S D, CHEN B C, KAO S T, et al．Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells [J]．BMC Complement Altern Med, 2014, 14: 26．
[28] KIM S J, PHAM T H, BAK Y, et al．Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKCα/ ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells [J]．Phytomedicine,2018, 50: 35-42．
[29] KIM S J, PHAM T H, BAK Y, et al．7-Methoxy-luteolin-8-C-β-6-deoxy-xylo-pyranos-3-uloside exactly (mLU8CPU)isolated from Arthraxon hispidus inhibits migratory and invasive responses mediated via downregulation of MMP-9 and IL-8 expression in MCF-7 breast cancer cells [J]．Environ Toxicol, 2018, 33(11): 1143-1152．
[30] LIRDPRAPAMONGKOL K, SAKURAI H, ABDELHAMED S, et al．A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells [J]．Oncol Rep, 2013 30(5): 2357-2364．
[31] LIN C M, SHYU K G, WANG B W, et al．Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach[J]．J Agric Food Chem, 2010, 58(11): 7082-7087．
[32] LI X, WANG J N, HUANG J M, et al．Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines [J]．Toxicol In Vitro, 2011, 25(3): 630-635．
[33] YANG B, HUANG J, XIANG T, et al．Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway[J]．J Appl Toxicol, 2014, 34(1): 105-112．
[34] XIA Y, LIAN S, KHOI P N, et al．Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells[J]．PLoS One, 2015, 10(4): e0124007．
[35] XIA Y, YUAN M, LI S, et al．Apigenin suppresses the IL-1β-induced expression of the urokinase-type plasminogen activator receptor by inhibiting MAPK-mediated AP-1 and NF-κB signaling in human bladder cancer T24 cells [J]．J Agric Food Chem, 2018, 66(29): 7663-7673．
[36] YEN H R, LIU C J, YEH C C．Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells [J]．Chem Biol Interact, 2015, 235: 1-9．
[37] SUN Y, WANG X, ZHOU Q, et al．Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo [J]．Oncol Rep, 2015, 33(1): 338-346．
[38] GUPTA S C, RAI V．Role of emodin in chemosensitization of cancer．In: BHARTI A C, AGGARWAL B B, eds．Role of nutraceuticals in cancer chemosensitization [M]．Massachusetts: Academic Press, 2018: 241-257．
[39] CHEN Y Y, CHIANG S Y, LIN J G, et al．Emodin, aloeemodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9 [J]．Int J Oncol,2010, 36(5): 1113-1120．
[40] ZHOU G, PENG F, ZHONG Y, et al．Rhein suppresses matrix metalloproteinase production by regulating the Rac/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells [J]．Int J Oncol, 2017, 50(3): 933-941．
[41] HUANG T S, LEE S C, LIN J K．Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells [J]．Proc Natl Acad Sci U S A, 1991,88(12): 5292-5296．
[42] HAN S S, KEUM Y S, SEO H J, et al．Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells [J]．J Biochem Mol Biol, 2002, 35(3): 337-342．
[43] SAIKI I．Curcumin and cancer metastasis．In: YOSHIDA K, CHEYNIER V, QUIDEAU S, eds．Recent advances in polyphenol research [M]．Hoboken: John Wiley & Sons,Ltd．, 2017: 290-312．
[44] PANG J S, YEN J H, WU H T, et al．Gallic acid inhibited matrix invasion and AP-1/ETS-1-mediated MMP-1 transcription in human nasopharyngeal carcinoma cells [J]．Int J Mol Sci, 2017, 18(7): pii E1354．
[45] CHAO C Y, LII C K, HSU Y T, et al．Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells [J]．Carcinogenesis, 2013,34(8): 1843-1851．
[46] YUAN M, MENG W, LIAO W, et al．Andrographolide antagonizes TNF-α-induced IL-8 via inhibition of NADPH oxidase/ROS/NF-κB and Src/MAPKs/AP-1 axis in human colorectal cancer HCT116 cells [J]．J Agric Food Chem,2018, 66(20): 5139-5148．
[47] HSIEH M J , CHEN J C , YANG W E , e t a l．Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-κB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition [J]．Biochem Pharmacol, 2017, 130: 10-20．
[48] SHIN S H, LEE S R, LEE E, et al．Caffeic acid phenethyl ester from the twigs of Cinnamomum cassia inhibits malignant cell transformation by inducing c-Fos degradation[J]．J Nat Prod, 2017, 80(7): 2124-2130．
[49] KHANFAR M A, EL SAYED K A．The Veratrum alkaloids jervine, veratramine, and their analogues as prostate cancer migration and proliferation inhibitors: biological evaluation and pharmacophore modeling [J]．Med Chem Res, 2013,22(10): 4775-4786．
[50] BAI F, LIU K, LI H, et al．Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA [J]．Nucleic Acids Res, 2018, 46(2):546-557．